Bio Green Med Solution (BGMS) Q4 2025 earnings summary

Executive summary

• Completed acquisition of Fitters Sdn. Bhd. in September 2025, shifting focus to fire safety protection and distribution.

• Liquidated UK subsidiary and sold Plogosertib drug asset, strengthening the balance sheet.

• Declared and paid a quarterly cash dividend on preferred stock in early 2026.

Financial highlights

• Cash and cash equivalents were $3.5 million as of December 31, 2025, down from $3.8 million a year earlier.

• Net cash used in operating activities was $4.8 million for 2025, improved from $8.0 million in 2024.

• Net loss for 2025 was $3.0 million, significantly reduced from $11.2 million in 2024.

• Product revenue from fire safety equipment was $0.7 million for both Q4 and full year 2025.

• Total other income, net, was $5.4 million for 2025, mainly from a $4.9 million gain on deconsolidation of the former subsidiary.

Outlook and guidance

• Current cash resources are expected to fund planned expenditures into Q3 2026.